Harnessing the patient’s immune system to cure cancer
Javelin’s multidimensional approach introduces a new capability to precision immune medicine. This enables us to predict patient responses to treatment, signiﬁcantly reducing the time and resources required to launch new immunotherapies.
We apply our platform both to create novel therapies in our own labs and as a service to other life sciences companies to help them advance their discovery and development of immuno-oncology therapies. Our goal is to utilize our capabilities to transform outcomes for as many patients as possible by creating effective and safe curative therapies. By making our technology available to others, we can amplify our impact.
Our team is passionate about redefining how we treat solid tumors by leveraging the body’s own immune system to generate therapies and cures that are effective but also create minimal side effects and toxicity in their application
Our multidimensional approach is enabling the biopharma industry to better predict target and treatment outcomes and design effective therapies. We believe we can have as much as a 10X impact in reducing the time and cost of getting these therapies to patients.
Develop treatments faster and at dramatically reduced costs using Javelin’s transformative services and tools.